Strategic Partnerships Leverage OGV’s established alliance with Panaxia and Israeli partners to position joint healthcare and pharmaceutical-grade cannabis solutions for US wellness channels, leveraging their science-first narrative to open doors with medical clinics, compounding pharmacies, and regulated distributors.

Regulatory Advantage Highlight the company’s strong emphasis on pharmaceutical manufacturing standards and access to Israeli research partnerships as a differentiator to US healthcare buyers seeking compliant, rigorously tested cannabis products and clinical trial-backed formulations.

Early Growth Opportunity With a lean team and revenue under one million, target early-stage wellness brands, hemp/CBD product formulators, and contract manufacturers looking for high-quality, research-backed cannabis solutions to accelerate market entry.

Narrative for Outreach Use the ‘Start-Up Nation’ and Israeli innovation story to craft compelling outreach for potential customers, partners, and investors who value cutting-edge agriculture tech, life sciences, and software integrated cannabis platforms.

Tech-Driven Scalability Position OGV’s technology stack and data capabilities (including MySQL, analytics, and cloud hosting) as a selling point for partners requiring scalable operations, traceability, and robust digital infrastructure to support compliant product development and distribution.